Hohl Benjamin
Insider CIK 1882764 · ELVN Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2026-10-19 | 2026-10-21 | 6,018 | — | $0 | 175,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-10-19 | 2026-10-21 | 6,018 | $38.48 | $231.5K | 38,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2026-10-19 | 2026-10-21 | 6,018 | $14.85 | $89.4K | 44,018 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2026-09-17 | 2026-09-21 | 3,982 | — | $0 | 181,018 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 289 | $51.49 | $14.9K | 38,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 2,194 | $50.72 | $111.3K | 38,289 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 3,535 | $50.03 | $176.9K | 40,483 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2026-09-17 | 2026-09-21 | 3,982 | $14.85 | $59.1K | 44,018 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2026-09-17 | 2026-09-21 | 3,982 | — | $0 | 181,018 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 289 | $51.49 | $14.9K | 38,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 2,194 | $50.72 | $111.3K | 38,289 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 3,535 | $50.03 | $176.9K | 40,483 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2026-09-17 | 2026-09-21 | 3,982 | $14.85 | $59.1K | 44,018 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 1,388 | $59.35 | $82.4K | 40,036 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 4,630 | $58.35 | $270.2K | 41,424 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 1,388 | $59.35 | $82.4K | 40,036 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 4,630 | $58.35 | $270.2K | 41,424 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2026-07-17 | 2026-07-21 | 1,072 | — | $0 | 84,966 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-07-17 | 2026-07-21 | 2,564 | $52.32 | $134.1K | 48,815 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-07-17 | 2026-07-21 | 369 | $51.48 | $19.0K | 51,379 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-07-17 | 2026-07-21 | 324 | $49.97 | $16.2K | 51,748 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2026-07-17 | 2026-07-21 | 1,072 | $2.48 | $2.7K | 52,072 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-07-17 | 2026-07-21 | 2,638 | $53.38 | $140.8K | 46,177 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-07-17 | 2026-07-21 | 123 | $53.87 | $6.6K | 46,054 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2026-06-17 | 2026-06-22 | 6,018 | — | $0 | 86,038 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-06-17 | 2026-06-22 | 1,379 | $42.79 | $59.0K | 55,639 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-06-17 | 2026-06-22 | 3,401 | $43.86 | $149.2K | 52,238 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-06-17 | 2026-06-22 | 1,238 | $44.75 | $55.4K | 51,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2026-06-17 | 2026-06-22 | 6,018 | $2.48 | $14.9K | 57,018 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-03-06 | 2026-03-10 | 10,000 | $29.58 | $295.8K | 51,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2026-02-12 | 2026-02-17 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award | 2026-02-12 | 2026-02-17 | 25,000 | — | $0 | 61,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-12-22 | 2025-12-23 | 13,000 | — | $0 | 92,056 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-12-22 | 2025-12-23 | 13,000 | $2.48 | $32.2K | 36,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-09-29 | 2025-10-01 | 3,250 | — | $0 | 105,056 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-09-29 | 2025-10-01 | 3,250 | $2.48 | $8.1K | 26,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-09-29 | 2025-10-01 | 3,250 | $20.40 | $66.3K | 23,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-08-27 | 2025-08-29 | 3,250 | — | $0 | 108,306 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-08-27 | 2025-08-29 | 3,250 | $2.48 | $8.1K | 26,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-08-27 | 2025-08-29 | 3,250 | $20.63 | $67.0K | 23,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-07-28 | 2025-07-30 | 3,250 | — | $0 | 111,556 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-07-28 | 2025-07-30 | 3,185 | $20.45 | $65.1K | 23,065 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-07-28 | 2025-07-30 | 65 | $21.30 | $1.4K | 23,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-07-28 | 2025-07-30 | 3,250 | $2.48 | $8.1K | 26,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-07-10 | 2025-07-14 | 1,000 | — | $0 | 114,806 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-07-10 | 2025-07-14 | 1,000 | $22.66 | $22.7K | 23,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-07-10 | 2025-07-14 | 1,000 | $2.48 | $2.5K | 24,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-06-27 | 2025-07-01 | 3,250 | — | $0 | 115,806 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-06-27 | 2025-07-01 | 198 | $21.66 | $4.3K | 23,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-06-27 | 2025-07-01 | 3,052 | $20.86 | $63.7K | 23,198 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-06-27 | 2025-07-01 | 3,250 | $2.48 | $8.1K | 26,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-06-13 | 2025-06-17 | 3,000 | — | $0 | 119,056 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-06-13 | 2025-06-17 | 3,000 | $2.48 | $7.4K | 26,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-06-13 | 2025-06-17 | 3,000 | $22.55 | $67.7K | 23,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-05-27 | 2025-05-29 | 3,250 | — | $0 | 122,056 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-05-27 | 2025-05-29 | 3,250 | $16.18 | $52.6K | 23,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-05-27 | 2025-05-29 | 3,250 | $2.48 | $8.1K | 26,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-04-28 | 2025-04-30 | 3,250 | — | $0 | 125,306 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-04-28 | 2025-04-30 | 69 | $19.12 | $1.3K | 23,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-04-28 | 2025-04-30 | 3,181 | $18.68 | $59.4K | 23,069 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-04-28 | 2025-04-30 | 3,250 | $2.48 | $8.1K | 26,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-03-27 | 2025-03-31 | 3,250 | — | $0 | 128,556 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-03-27 | 2025-03-31 | 3,250 | $2.48 | $8.1K | 26,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-03-27 | 2025-03-31 | 3,250 | $21.33 | $69.3K | 23,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-03-24 | 2025-03-26 | 1,000 | — | $0 | 131,806 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-03-24 | 2025-03-26 | 1,000 | $22.50 | $22.5K | 23,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-03-24 | 2025-03-26 | 1,000 | $2.48 | $2.5K | 24,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-03-04 | 2025-03-06 | 10,000 | — | $0 | 132,806 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-03-04 | 2025-03-06 | 10,000 | $2.48 | $24.8K | 23,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-02-27 | 2025-03-03 | 3,250 | — | $0 | 142,806 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-02-27 | 2025-03-03 | 3,250 | $2.48 | $8.1K | 16,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-02-27 | 2025-03-03 | 3,250 | $20.41 | $66.3K | 13,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2025-02-06 | 2025-02-10 | 171,000 | — | $0 | 171,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-02-05 | 2025-02-07 | 1,000 | — | $0 | 146,056 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-02-05 | 2025-02-07 | 1,000 | $22.52 | $22.5K | 13,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-02-05 | 2025-02-07 | 1,000 | $2.48 | $2.5K | 14,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-01-27 | 2025-01-29 | 3,250 | — | $0 | 147,056 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-01-27 | 2025-01-29 | 3,250 | $2.48 | $8.1K | 16,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-01-27 | 2025-01-29 | 3,250 | $21.59 | $70.2K | 13,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2025-01-03 | 2025-01-07 | 1,000 | — | $0 | 150,306 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2025-01-03 | 2025-01-07 | 1,000 | $2.48 | $2.5K | 14,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-01-03 | 2025-01-07 | 1,000 | $25.04 | $25.0K | 13,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-12-30 | 2024-12-31 | 900 | — | $0 | 164,306 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-12-30 | 2024-12-31 | 900 | $2.48 | $2.2K | 900 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-12-30 | 2024-12-31 | 900 | $22.51 | $20.3K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-12-27 | 2024-12-31 | 3,350 | — | $0 | 165,206 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-12-27 | 2024-12-31 | 3,350 | $22.15 | $74.2K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-12-27 | 2024-12-31 | 3,350 | $2.48 | $8.3K | 3,350 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-12-13 | 2025-01-07 | 13,000 | — | $0 | 155,556 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-12-13 | 2025-01-07 | 13,000 | $2.48 | $32.2K | 13,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-11-27 | 2024-12-02 | 5,250 | — | $0 | 168,556 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-11-27 | 2024-12-02 | 1,000 | $25.38 | $25.4K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-11-27 | 2024-12-02 | 4,250 | $24.78 | $105.3K | 1,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-11-27 | 2024-12-02 | 5,250 | $2.48 | $13.0K | 5,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-10-28 | 2024-10-30 | 6,250 | — | $0 | 173,806 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-28 | 2024-10-30 | 5,600 | $28.49 | $159.5K | 650 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-28 | 2024-10-30 | 650 | $29.11 | $18.9K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-10-28 | 2024-10-30 | 6,250 | $2.48 | $15.5K | 6,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-10-18 | 2024-10-22 | 814 | — | $0 | 180,056 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-22 | 814 | $30.00 | $24.4K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-10-18 | 2024-10-22 | 814 | $2.48 | $2.0K | 814 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-10-07 | 2024-10-08 | 1,270 | — | $0 | 180,870 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-07 | 2024-10-08 | 1,270 | $27.51 | $34.9K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-10-07 | 2024-10-08 | 1,270 | $2.48 | $3.1K | 2,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-10-04 | 2024-10-08 | 10,218 | — | $0 | 182,140 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-10-04 | 2024-10-08 | 10,218 | $2.48 | $25.3K | 10,218 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-04 | 2024-10-08 | 10,218 | $27.51 | $281.1K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-10-01 | 2024-10-03 | 521 | — | $0 | 192,358 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 521 | $27.54 | $14.3K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-10-01 | 2024-10-03 | 521 | $2.48 | $1.3K | 521 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-09-30 | 2024-10-01 | 2,000 | — | $0 | 192,879 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-09-30 | 2024-10-01 | 2,000 | $25.33 | $50.7K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-09-30 | 2024-10-01 | 2,000 | $2.48 | $5.0K | 2,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-09-27 | 2024-10-01 | 4,250 | — | $0 | 194,879 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-09-27 | 2024-10-01 | 4,250 | $2.48 | $10.5K | 4,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-09-27 | 2024-10-01 | 4,250 | $24.27 | $103.1K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-08-27 | 2024-08-29 | 4,250 | — | $0 | 199,129 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-08-27 | 2024-08-29 | 4,250 | $2.48 | $10.5K | 4,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-08-27 | 2024-08-29 | 4,250 | $22.54 | $95.8K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-07-31 | 2024-08-02 | 991 | — | $0 | 203,379 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-07-31 | 2024-08-02 | 991 | $27.53 | $27.3K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-07-31 | 2024-08-02 | 991 | $2.48 | $2.5K | 991 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-07-29 | 2024-07-31 | 5,250 | — | $0 | 204,370 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-07-29 | 2024-07-31 | 5,250 | $2.48 | $13.0K | 5,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-07-29 | 2024-07-31 | 61 | $27.44 | $1.7K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-07-29 | 2024-07-31 | 5,189 | $26.67 | $138.4K | 61 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-07-12 | 2024-07-16 | 3,000 | — | $0 | 209,620 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-07-12 | 2024-07-16 | 3,000 | $25.07 | $75.2K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-07-12 | 2024-07-16 | 3,000 | $2.48 | $7.4K | 3,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-06-27 | 2024-07-01 | 4,250 | — | $0 | 212,620 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-06-27 | 2024-07-01 | 1,140 | $23.43 | $26.7K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-06-27 | 2024-07-01 | 4,250 | $2.48 | $10.5K | 4,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-06-27 | 2024-07-01 | 1,280 | $21.79 | $27.9K | 2,970 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-06-27 | 2024-07-01 | 1,830 | $22.58 | $41.3K | 1,140 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-05-28 | 2024-05-30 | 4,250 | — | $0 | 216,870 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-05-28 | 2024-05-30 | 2,334 | $23.42 | $54.7K | 10 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-05-28 | 2024-05-30 | 4,250 | $2.48 | $10.5K | 4,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-05-28 | 2024-05-30 | 10 | $24.34 | $243 | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-05-28 | 2024-05-30 | 1,906 | $22.89 | $43.6K | 2,344 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-05-03 | 2024-05-07 | 1,000 | — | $0 | 221,120 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-05-03 | 2024-05-07 | 1,000 | $2.48 | $2.5K | 1,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-05-03 | 2024-05-07 | 1,000 | $22.50 | $22.5K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-04-29 | 2024-05-01 | 3,250 | — | $0 | 222,120 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-04-29 | 2024-05-01 | 3,250 | $2.48 | $8.1K | 3,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-04-29 | 2024-05-01 | 3,250 | $16.97 | $55.2K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-04-11 | 2024-04-15 | 14,000 | — | $0 | 225,370 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-04-11 | 2024-04-15 | 10,223 | $25.04 | $256.0K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-04-11 | 2024-04-15 | 3,777 | $23.88 | $90.2K | 10,223 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-04-11 | 2024-04-15 | 14,000 | $2.48 | $34.7K | 14,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-03-27 | 2024-03-29 | 3,250 | — | $0 | 239,370 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-03-27 | 2024-03-29 | 3,250 | $2.48 | $8.1K | 3,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-03-27 | 2024-03-29 | 3,068 | $18.22 | $55.9K | 182 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-03-27 | 2024-03-29 | 182 | $18.72 | $3.4K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-02-27 | 2024-02-29 | 3,250 | — | $0 | 242,620 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-02-27 | 2024-02-29 | 3,250 | $2.48 | $8.1K | 3,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-02-27 | 2024-02-29 | 3,250 | $16.97 | $55.2K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2024-02-13 | 2024-02-15 | 185,000 | — | $0 | 185,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-01-29 | 2024-01-31 | 3,250 | — | $0 | 245,870 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-01-29 | 2024-01-31 | 3,250 | $2.48 | $8.1K | 3,250 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-01-29 | 2024-01-31 | 3,250 | $15.81 | $51.4K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-01-02 | 2024-01-02 | 9,383 | — | $0 | 249,120 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-01-02 | 2024-01-02 | 9,383 | $15.01 | $140.8K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-01-02 | 2024-01-02 | 9,383 | $2.48 | $23.3K | 9,383 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2023-12-29 | 2024-01-02 | 20 | — | $0 | 258,503 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-29 | 2024-01-02 | 20 | $15.00 | $300 | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2023-12-29 | 2024-01-02 | 20 | $2.48 | $50 | 20 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2023-12-28 | 2024-01-02 | 2,467 | — | $0 | 258,523 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2023-12-28 | 2024-01-02 | 2,467 | $2.48 | $6.1K | 2,467 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-28 | 2024-01-02 | 2,467 | $15.07 | $37.2K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2023-12-26 | 2023-12-27 | 100 | — | $0 | 260,990 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2023-12-26 | 2023-12-27 | 100 | $2.48 | $248 | 100 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-26 | 2023-12-27 | 100 | $15.00 | $1.5K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2023-12-22 | 2023-12-27 | 1,030 | — | $0 | 261,090 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2023-12-22 | 2023-12-27 | 1,030 | $2.48 | $2.6K | 1,030 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-22 | 2023-12-27 | 1,030 | $15.07 | $15.5K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2023-04-04 | 2023-04-06 | 206,000 | — | $0 | 206,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2023-02-23 | 2023-02-27 | 262,120 | — | $0 | 262,120 | SEC↗ |